Business Standard

Breast cancer startup Niramai gets $6 mn from Dream Incubator, Binny Bansal

Niramai has developed an artificial intelligence-based solution for detecting early-stage breast cancer.

Fighting breast cancer with AI-powered mobile, non-invasive solutions
Premium

Peerzada Abrar
Artificial intelligence-based healthcare startup Niramai Health Analytix has raised $6 million in a Series A funding round led by Japanese venture capital firm Dream Incubator. 

Beenext, earlier investors pi Ventures, Ankur Capital, Axilor Ventures, and Flipkart co-founder Binny Bansal also participated in the round. The firm will use the funds for scaling up its presence in India, hiring top talent and getting additional regulatory approvals for international expansion.

Niramai has developed a patented technology called ‘Thermalytix’, which is a non-contact and non-invasive solution for early-stage breast cancer detection. The solution is clinically proven to be accurate for women of all age groups.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in